Tag: BioArctic
Eisai reports comparable drug exposure with subcutaneous lecanemab initiation regimen
Data presented at AAIC 2026 support further evaluation of a once-weekly 500 mg autoinjector regimen as an alternative to intravenous initiation in early Alzheimer’s...